Gene51171
HSD17B14: hydroxysteroid 17-beta dehydrogenase 14
Cite this record
ConductScience Library. HSD17B14: hydroxysteroid 17-beta dehydrogenase 14. Genes, record 51171. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/51171
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BPX1 | L-fucose dehydrogenase | 270 | 31 | Ensembl, GeneID, HGNC |
Source UniProt
Patents246
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 49553 | Q9BPX1 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 5186 | Q9BPX1 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 5186 | Q9BPX1 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 19131 | Q9BPX1 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 49553 | Q9BPX1 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 190156 | Q9BPX1 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 39308 | Q9BPX1 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 39308 | Q9BPX1 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 39308 | Q9BPX1 | Espacenet |
| JP 2022092366 A | 2022-06-22 | 700 | Q9BPX1 | Espacenet |
NIH grants205
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HSD17B14 papers | Newest fiscal year |
|---|---|---|---|
| P30ES013508 | Center of Excellence in Environmental Toxicology | 3 | 2025 |
| P30DK036836 | Diabetes Research Center | 2 | 2025 |
| R01EY009339 | Retinoids in Vision | 2 | 2025 |
| T32ES018827 | Research Training in Environmental Toxicology | 2 | 2025 |
| ZICES102445 | Gene Expression and Microarrays | 2 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 1 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 1 | 2025 |
| P30DK120515 | San Diego Digestive Diseases Research Center | 1 | 2025 |
| P30ES019776 | HERCULES: Exposome Research Center | 1 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 1 | 2025 |
Source NIH's project files
Papers171
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Profiling Identifies Novel Therapeutic Targets and Pathobiological Mechanisms in Oral Cancer. | J Cell Mol Med | 2026 | 42548293 | PubTator, text mining | PubMed |
| Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1. | Biomark Res | 2026 | 42106890 | PubTator, text mining | PubMed |
| Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1. | Res Sq | 2026 | 42052237 | PubTator, text mining | PubMed |
| Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1. | medRxiv | 2026 | 41742944 | PubTator, text mining | PubMed |
| How Much Can the Genotype Predict Phenotypical Power Performance in Elite Male and Female Athletes? | J Hum Kinet | 2025 | 39944982 | PubTator, text mining | PubMed |
| Advocating individual-based profiles of elite athletes to capture the multifactorial nature of elite sports performance. | Sci Rep | 2024 | 39487215 | PubTator, text mining | PubMed |
| Hydroxysteroid 17-β dehydrogenase 14 (HSD17B14) is an L-fucose dehydrogenase, the initial enzyme of the L-fucose degradation pathway. | J Biol Chem | 2024 | 38944119 | Swiss-Prot, curated | PubMed |
| DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. | Kidney Int | 2024 | 38782200 | PubTator, text mining | PubMed |
| Development of a clinical prediction model for diabetic kidney disease with glucose and lipid metabolism disorders based on machine learning and bioinformatics technology. | Eur Rev Med Pharmacol Sci | 2024 | 38375694 | PubTator, text mining | PubMed |
| A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma. | PLoS One | 2024 | 38324544 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51171
GET https://conductscience.org/api/genes/v1/51171/patents?page=2